<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-040301</identifier>
<setSpec>0213-9111</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Competing risks of death and Hardy-Weinberg equilibrium in case-control studies of gene-disease association</dc:title>
<dc:description xml:lang="en">Objective: To study the impact of competing risks on Hardy-Weinberg equilibrium and their consequences in case-control studies of gene-late onset disease association. Methods: Based on a population born in Hardy-Weinberg equilibrium for a particular gene, the genetic composition when the gene is associated with a lethal early-onset disease and its consequences on a late-onset disease can be deduced. Odds ratios estimates are unbiased in case-control studies when controls are sampled by density, even if the controls are in Hardy-Weinberg disequilibrium. Results: An example in which a mutant gene is associated with early mortality is presented, producing a departure from Hardy-Weinberg equilibrium; as a result, controls in later ages are in disequilibrium, producing an odds ratio equal to 1.61. Conclusion: Although the main causes of Hardy-Weinberg disequilibrium in controls are selection bias or genotyping error, a competing risk of death associated with the mutant gene would also result in Hardy-Weinberg disequilibrium among controlsObjective: To study the impact of competing risks on Hardy-Weinberg equilibrium and their consequences in case-control studies of gene-late onset disease association. Methods: Based on a population born in Hardy-Weinberg equilibrium for a particular gene, the genetic composition when the gene is associated with a lethal early-onset disease and its consequences on a late-onset disease can be deduced. Odds ratios estimates are unbiased in case-control studies when controls are sampled by density, even if the controls are in Hardy-Weinberg disequilibrium. Results: An example in which a mutant gene is associated with early mortality is presented, producing a departure from Hardy-Weinberg equilibrium; as a result, controls in later ages are in disequilibrium, producing an odds ratio equal to 1.61. Conclusion: Although the main causes of Hardy-Weinberg disequilibrium in controls are selection bias or genotyping error, a competing risk of death associated with the mutant gene would also result in Hardy-Weinberg disequilibrium among controls</dc:description>
<dc:creator>Combarros, Onofre</dc:creator>
<dc:creator>Berciano, José</dc:creator>
<dc:creator>Prieto-Salceda, Dolores</dc:creator>
<dc:creator>Llorca, Javier</dc:creator>
<dc:creator>Dierssen-Sotos, Trinidad</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Estudiar el impacto de los riesgos competitivos sobre el equilibrio de Hardy-Weinberg y sus consecuencias en los estudios de casos y controles sobre la relación gen-enfermedades de comienzo tardío. Métodos: A partir de una población que, respecto de un determinado gen, se encuentre en equilibrio de Hardy-Weinberg al nacer, se deduce la composición genética cuando el gen está asociado con una enfermedad letal de aparición precoz, y sus consecuencias sobre una enfermedad de comienzo tardío. Cuando se realiza un estudio de casos y controles con muestreo por densidad se obtiene una estimación no sesgada de la odds ratio, a pesar de que los controles no estén en equilibrio de Hardy-Weinberg. Resultados: Se presenta un ejemplo en el que el gen mutante se asocia con una mayor mortalidad precoz al romper el equilibrio de Hardy-Weinberg y da lugar a que en un estudio realizado en edades más avanzadas los controles se encuentren en desequilibrio, con una odds ratio de 1,61. Conclusión: Aunque las principales causas de desequilibrio de Hardy-Weinberg en los controles son un sesgo de selección o un error de genotipificación, un riesgo competitivo de muerte asociado con el gen mutante puede ocasionar que la muestra de controles esté en desequilibrio de Hardy-Weinberg</dc:description>
<dc:source>Gac Sanit;19(4): 321-324, jul. 2005. ilus, graf</dc:source>
<dc:identifier>ibc-040301</dc:identifier>
<dc:title xml:lang="es">Riesgos competitivos de muerte y equilibrio de Hardy-Weinberg en estudios de casos y controles sobre asociación entre genes y enfermedades</dc:title>
<dc:subject>^d9346</dc:subject>
<dc:subject>^d4258^s22080</dc:subject>
<dc:subject>^d5974</dc:subject>
<dc:subject>^d24811</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d5928^s22033</dc:subject>
<dc:subject>^d5942</dc:subject>
<dc:subject>^d24872</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:type>article</dc:type>
<dc:date>200507</dc:date>
</metadata>
</record>
</ibecs-document>
